Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d) On July 9, 2021, the Board of Directors (the "Board") of Flexion
Therapeutics, Inc. (the "Company") appointed Mr. Utpal Koppikar as a director of
the Company. Mr. Koppikar will serve as a Class II director with an initial term
expiring at the Company's 2022 annual meeting of stockholders, or until his
earlier death, resignation, or removal. Mr. Koppikar was also appointed to serve
as a member and Chair of the Audit Committee of the Board, replacing Mr. Patrick
Mahaffy, who was serving in an interim role as a member and Chair of that
Committee.
Mr. Koppikar will receive compensation in accordance with the Company's
Non-Employee Director Compensation Policy previously filed as Exhibit 10.6 to
the Company's Annual Report on Form 10-K filed with the Securities and Exchange
Commission on March 12, 2020. The Company also entered into a standard form of
indemnity agreement with Mr. Koppikar effective upon his appointment to the
Board.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
FLEXION THERAPEUTICS, INC. 